912287-56-0 Usage
General Description
YHO-13177 is a pyrazole-based compound that has been studied for its potential therapeutic applications. It has been shown to have binding activity with the target protein androgen receptor, suggesting a potential role in the treatment of prostate cancer and other androgen receptor-related diseases. Additionally, it exhibits cytotoxic effects against cancer cells and has been investigated for its potential as a chemotherapeutic agent. YHO-13177 also has anti-inflammatory and anti-tumor properties, making it a promising candidate for further development as a potential drug for cancer treatment. Further research is needed to fully understand its mechanisms of action and potential applications in the field of oncology.
Check Digit Verification of cas no
The CAS Registry Mumber 912287-56-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,2,2,8 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 912287-56:
(8*9)+(7*1)+(6*2)+(5*2)+(4*8)+(3*7)+(2*5)+(1*6)=170
170 % 10 = 0
So 912287-56-0 is a valid CAS Registry Number.
912287-56-0Relevant articles and documents
ABCG2 INHIBITOR
-
Page/Page column 5; 7-8, (2010/08/22)
The present invention relates to a breast cancer resistance protein (BCRP/ABCG2) inhibitor. The invention provides an acrylonitrile derivative represented by formula (1): (wherein A represents an optionally substituted 3- to 8-membered heterocyclic ring)
